Table 2 Summary of Culture and LPA/APM in patients with rifampicin resistant Xpert
Test | Rifampicin sensitive | Rifampicin monoresistant | MDR-TB | Inconclusive |
|---|---|---|---|---|
Culture and LPA (N = 180) | 14 (7.8%) | 30 (16.7%) | 130 (72.2%) | 6 (3.3%) |
Culture and APM (N = 226) | 11 (4.9%) | 31 (13.7%) | 184 (81.4%) | 0 (0.0%) |
Total Confirmed (N = 262) | 23 (8.8%; | 35 (13.4%; | 204 (77.8%; | N/A |
5.4-12.2%) | 9.2-17.5%) | 72.8-82.9%) | N/A |